Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause Recurrent cancer? 8 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Recurrent cancer have been filed in association with DOCETAXEL\DOCETAXEL ANHYDROUS. This represents 0.2% of all adverse event reports for DOCETAXEL\DOCETAXEL ANHYDROUS.
8
Reports of Recurrent cancer with DOCETAXEL\DOCETAXEL ANHYDROUS
0.2%
of all DOCETAXEL\DOCETAXEL ANHYDROUS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Recurrent cancer From DOCETAXEL\DOCETAXEL ANHYDROUS?
Of the 8 reports, 2 (25.0%) required hospitalization, and 2 (25.0%) were considered life-threatening.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOCETAXEL\DOCETAXEL ANHYDROUS. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause?
Diarrhoea (409)
Myelosuppression (404)
Disease progression (289)
Off label use (281)
Nausea (279)
Neutropenia (250)
Fatigue (236)
Pyrexia (221)
Vomiting (216)
Asthenia (190)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which DOCETAXEL\DOCETAXEL ANHYDROUS Alternatives Have Lower Recurrent cancer Risk?
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCOSANOL
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE